Harmony Biosciences Holdings Inc HRMY:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
31.79quote price arrow up+0.22 (+0.70%)
Volume
13,644
Close
31.57quote price arrow down-0.12 (-0.38%)
Volume
532,478
52 week range
18.61 - 39.26
Loading...
  • Open31.79
  • Day High32.37
  • Day Low31.17
  • Prev Close31.69
  • 52 Week High39.26
  • 52 Week High Date09/13/23
  • 52 Week Low18.61
  • 52 Week Low Date10/13/23

Key Stats

  • Market Cap1.793B
  • Shares Out56.79M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta0.75
  • YTD % Change-2.26

KEY STATS

  • Open31.79
  • Day High32.37
  • Day Low31.17
  • Prev Close31.69
  • 52 Week High39.26
  • 52 Week High Date09/13/23
  • 52 Week Low18.61
  • 52 Week Low Date10/13/23
  • Market Cap1.793B
  • Shares Out56.79M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta0.75
  • YTD % Change-2.26

RATIOS/PROFITABILITY

  • EPS (TTM)2.32
  • P/E (TTM)13.63
  • Fwd P/E (NTM)14.50
  • EBITDA (TTM)228.059M
  • ROE (TTM)28.73%
  • Revenue (TTM)617.511M
  • Gross Margin (TTM)79.28%
  • Net Margin (TTM)22.30%
  • Debt To Equity (MRQ)36.86%

EVENTS

  • Earnings Date07/30/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Harmony Biosciences Holdings Inc

 

Profile

MORE
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company. The Company is focused on developing and commercializing therapies for patients living with rare neurological diseases as well as patients living with other neurological diseases who have unmet medical needs. Its product, WAKIX (pitolisant), is a first-in-class molecule with a novel mechanism of action (MOA) designed to enhance histamine signaling in the brain by binding to H3 receptors. Its...
Jeffrey Aronin
Non-Executive Chairman of the Board
Jeffrey Dayno M.D.
President, Chief Executive Officer, Director
Sandip Kapadia CPA
Chief Financial Officer, Chief Administrative Officer
Address
630 W Germantown Pike, Suite 215
Plymouth Meeting, PA
19462
United States

Top Peers

SYMBOLLASTCHG%CHG
SUPN
Supernus Pharmaceuticals Inc
30.83+0.56+1.85%
AMPH
Amphastar Pharmaceuticals Inc
42.46-0.20-0.47%
PCRX
Pacira Biosciences Inc
27.21-0.11-0.40%
COLL
Collegium Pharmaceutical Inc
37.51UNCHUNCH
ANIP
ANI Pharmaceuticals Inc
67.25+0.14+0.21%